Woman looking at prescription medication
·
4 Min Read

FDA moves to change labeling on buprenorphine dosing

Higher doses of the medication for opioid-use disorder are sometimes needed. Payers must follow the FDA’s lead to help save lives.

Behavioral Health
Physician or health care professional reviewing patient lab results on a computer desktop
UPDATED
·
3 Min Read

Addressing and managing drug shortages

The AMA has declared drug shortages to be an urgent public health crisis. Stay informed and access resources to address the impacts on practice.

Federal Advocacy
·
5 Min Read

Feb. 7, 2025: National Advocacy Update

Physicians to CMS: Connect MIPS Value Pathways to patient care and more in the latest National Advocacy Update.

Advocacy Update
·
3 Min Read

Feb. 7, 2025: State Advocacy Update

Colorado, Virginia, Washington advancing bills on mental health and substance use disorder parity and more in the latest State Advocacy Update.

Advocacy Update
Person shopping for cannabis products
·
4 Min Read

If it’s marketed as cannabis, it needs a warning label

Cannabis use disorder on the rise among youth and pregnant people, driven by targeted marketing. AMA model bill would give consumers more information.

Behavioral Health
·
3 Min Read

Top news stories from AMA Morning Rounds®: Week of Jan. 27, 2025

In the news: SARS-CoV-2 reinfection linked to long COVID risk, threat of human bird flu pandemic grows, FDA approves new nonopioid pain medication and more.

Publications & Newsletters
Two vapes
·
4 Min Read

Flavored e-cigarettes pose dire threat to youth and public health

Keeping candy- and fruit-flavored e-liquids and e-cigarettes out of the hands of young people will help prevent a lifetime of nicotine addiction. 

series
Leadership
Leadership Viewpoints
AMA Update for Jan. 22, 2025: Ozempic study on weight loss drugs side effects, FDA red dye 3 ban, flu cases and norovirus vaccine
·
12 Min Read

Ozempic study on weight loss drugs side effects, FDA red dye 3 ban, flu cases and norovirus vaccine

The AMA Update covers a range of health care topics affecting the lives of physicians and patients. Learn more about new research on how GLP-1 drugs, bird flu and more.

series
Chronic Diseases
AMA Update
·
12 Min Read

Ozempic study on weight loss drugs side effects, FDA red dye 3 ban, flu cases and norovirus vaccine [Podcast]

The AMA Update covers a range of health care topics affecting the lives of physicians and patients. Learn more about new research on how GLP-1 drugs, bird flu and more.

series
Chronic Diseases
AMA Update Podcast